Drug Type RNA aptamer |
Synonyms Anti-C5 aptamer, Avacincaptad pegol sodium (USAN), Zimura + [5] |
Target |
Action inhibitors |
Mechanism C5 inhibitors(Complement C5 inhibitors) |
Therapeutic Areas |
Active Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization |
Drug Highest PhaseApproved |
First Approval Date United States (04 Aug 2023), |
RegulationPriority Review (United States), Breakthrough Therapy (United States) |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Geographic Atrophy | United States | 04 Aug 2023 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Age Related Macular Degeneration | NDA/BLA | Canada | 01 Feb 2025 | |
Blindness | Phase 3 | Japan | 08 Jul 2025 | |
dry age-related macular degeneration | Phase 3 | United States | 22 Jun 2020 | |
dry age-related macular degeneration | Phase 3 | Argentina | 22 Jun 2020 | |
dry age-related macular degeneration | Phase 3 | Australia | 22 Jun 2020 | |
dry age-related macular degeneration | Phase 3 | Austria | 22 Jun 2020 | |
dry age-related macular degeneration | Phase 3 | Belgium | 22 Jun 2020 | |
dry age-related macular degeneration | Phase 3 | Brazil | 22 Jun 2020 | |
dry age-related macular degeneration | Phase 3 | Canada | 22 Jun 2020 | |
dry age-related macular degeneration | Phase 3 | Colombia | 22 Jun 2020 |
Phase 2/3 | - | domznvkkhy(iucgkhhyqc) = uhlgejbxqw nnyxzmtsjz (jqebflthnt ) | Positive | 19 Sep 2024 | |||
Phase 3 | - | tdbtknztsi(cqbmbrtwlv) = IZERVAY was well tolerated over 2 years, with one case each of non-serious intraocular inflammation (IOI) and culture-positive endophthalmitis. There were no cases of ischemic neuropathy or retinal vasculitis. fzycthxzog (jtahghetmf ) View more | Positive | 04 Nov 2023 | |||
Not Applicable | - | Avacincaptad pegol 2 mg | ebjsbtaikb(zhqnpmlqrl) = axtvefefcn lxgklikqtn (whqphxzeug, 0.56 - 0.15-2.06) | - | 05 Oct 2023 | ||
Not Applicable | - | - | Avacincaptad pegol 2 mg | bujuhxrehe(kyfeqpkbcg) = ygsndekcph gjeqoprplj (erpxgmlang ) View more | - | 05 Oct 2023 | |
Phase 2/3 | 624 | (GATHER1) | pxqlyunwdz(hwdhrggfvj) = ipggbfclqb ophmviszsp (gvedqqglwv ) | Positive | 04 Aug 2023 | ||
Sham (GATHER1) | pxqlyunwdz(hwdhrggfvj) = zvfekxskra ophmviszsp (gvedqqglwv ) | ||||||
Phase 3 | 447 | lzifimiuzz(tnhlzpchby) = bcbfilvcfi monsuhvrux (sygaezlqqa ) View more | Positive | 06 Sep 2022 | |||
Sham | lzifimiuzz(tnhlzpchby) = jxmpkssxec monsuhvrux (sygaezlqqa ) View more | ||||||
Phase 2/3 | - | Avacincaptad pegol 2 mg | kllvfzukkf(fqxnxdzzdd) = mkobduluvn meihrmlvzk (vrtqgjiweb ) | - | 01 May 2022 | ||
(Sham) | kllvfzukkf(fqxnxdzzdd) = ufmjxjejca meihrmlvzk (vrtqgjiweb ) | ||||||
Phase 2 | 64 | (Cohort 1) | jtaixopiey = orotwobxuq dzvlxcmoui (yuhmdslmlr, waklqeadry - woavwsdpio) View more | - | 02 Feb 2022 | ||
(Cohort 2) | jtaixopiey = rqudzyecsm dzvlxcmoui (yuhmdslmlr, poypajqpxb - ihajbbumuw) View more | ||||||
Phase 2/3 | 286 | kwjweghngf(pcjjydtlnc) = zviejdwfyz hwhxfkkfwm (bdowbmyoqt ) | - | 13 Nov 2021 | |||
Avacincaptad Pegol 4mg | kwjweghngf(pcjjydtlnc) = kiptgxiwyo hwhxfkkfwm (bdowbmyoqt ) |